Gramicidin S: a peptide model for protein glycation and reversal of glycation using nucleophilic amines

被引:7
作者
Shakkottai, VG
Sudha, R
Balaram, P [1 ]
机构
[1] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India
[2] Jawaharlal Nehru Ctr Adv Sci Res, Chem Biol Unit, Bangalore 560012, Karnataka, India
来源
JOURNAL OF PEPTIDE RESEARCH | 2002年 / 60卷 / 02期
关键词
advanced glycation end products; Amadori rearrangement; gramicidin S; peptide glycation; protein glycation;
D O I
10.1034/j.1399-3011.2002.02901.x
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Nonenzymatic glycation of proteins has been implicated in various diabetic complications and age-related disorders. Proteins undergo glycation at the N-terminus or at the c.-amino group of lysine residues. Glycation of proteins proceeds through the stages of Schiff base formation, conversion to ketoamine product and advanced glycation end products. Gramicidin S, which has two ornithine residues, was used as a model system to study the various stages of glycation of proteins using electrospray ionization mass spectrometry. The proximity of two ornithine residues in the peptide favors the glycation reaction. Formation of advanced glycation end products and diglycation on ornithine residues in gramicidin S were observed. The formation of Schiff base adduct is reversible, whereas the Amadori rearrangement to the ketoamine product is irreversible. Nucleophilic amines and hydrazines can deglycate the Schiff base adduct of glucose with peptides and proteins. Hydroxylamine, isonicotinic acid hydrazide and aminoguanidine effectively removed glucose from the Schiff base adduct of gramicidin S. Hydroxylamine is more effective in deglycating the adduct compared with isonicotinic acid hydrazide and aminoguanidine. The observation that the hydrazines are effective in deglycating the Schiff base adduct even in the presence of high concentrations of glucose, may have a possible therapeutic application in preventing complications of diabetes mellitus. Hydrazines may be used to distinguish between the Schiff base and the ketoamine products formed at the initial stages of glycation.
引用
收藏
页码:112 / 120
页数:9
相关论文
共 48 条
[1]  
ACHARYA AS, 1980, J BIOL CHEM, V255, P7218
[2]  
ACHARYA AS, 1983, J BIOL CHEM, V258, P2296
[3]   NONENZYMATIC GLYCOSYLATION OF ERYTHROCYTIC PROTEINS IN NORMAL AND DIABETIC SUBJECTS - ENZYMES OF NUCLEOSIDE AND NUCLEOTIDE-METABOLISM [J].
AGARWAL, KC ;
PARKS, RE ;
WIDNESS, JA ;
SCHWARTZ, R .
DIABETES, 1985, 34 (03) :251-255
[4]  
AHMED MU, 1986, J BIOL CHEM, V261, P4889
[5]   An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness [J].
Asif, M ;
Egan, J ;
Vasan, S ;
Jyothirmayi, GN ;
Masurekar, MR ;
Lopez, S ;
Williams, C ;
Torres, RL ;
Wagle, D ;
Ulrich, P ;
Cerami, A ;
Brines, M ;
Regan, TJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2809-2813
[6]   A spectroscopic study of glycated bovine α-crystallin:: investigation of flexibility of the C-terminal extension, chaperone activity and evidence for diglycation [J].
Blakytny, R ;
Carver, JA ;
Harding, JJ ;
Kilby, GW ;
Sheil, MM .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1997, 1343 (02) :299-315
[7]   In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs) - Novel inhibition of post-Amadori glycation pathways [J].
Booth, AA ;
Khalifah, RG ;
Todd, P ;
Hudson, BG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (09) :5430-5437
[8]   Negative consequences of glycation [J].
Brownlee, M .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (02) :9-13
[9]   AMINOGUANIDINE PREVENTS DIABETES-INDUCED ARTERIAL-WALL PROTEIN CROSS-LINKING [J].
BROWNLEE, M ;
VLASSARA, H ;
KOONEY, A ;
ULRICH, P ;
CERAMI, A .
SCIENCE, 1986, 232 (4758) :1629-1632
[10]  
Cai J, 1999, J MASS SPECTROM, V34, P537